Alzheimer's - Dementia, Author Interviews, Cannabis / 03.09.2014
Cannabis Component May Protect Against Alzheimer’s Disease Progression
MedicalResearch.com Interview with:
Chuanhai Cao Ph.D.
Neuroscientist at the Byrd Alzheimer's Institute
and the USF College of Pharmacy.
Medical Research: What are the main findings of the study?
Dr. Cao: The major goal of this study was to investigate the effect of Ä9-tetrahydrocannabinol (THC), a major component of marijuana, on Alzheimer’s disease (AD) pathology. THC has long been known to have anti-inflammatory effects, but we were looking to determine whether THC directly affected amyloid beta (Aâ). Aâ aggregation is considered one of the key pathological hallmarks of Alzheimer’s disease. Our study showed that extremely low doses of THC were able to decrease Aâ production, inhibit Aâ aggregation, and enhance mitochondrial function in a cellular model of AD. Decreased levels of amyloid beta, coupled with THC’s inhibitory effect on aggregation may protect against the progression of Alzheimer’s disease.


















